Among them, the lncRNA antisense noncoding RNA in the INK4 locus (ANRIL), also identified as CDKN2B antisense RNA1, promotes cell migration, invasion, lymphangiogenesis, and lymphatic metastasis, all of which are related to the survival of CRC patients [5, 6]. The gene discussed is CDKN2B-AS1; the disease is colorectal carcinoma.